MetaCap

Aldeyra Therapeutics Statistics

NASDAQ: ALDXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.84+0.1183 (+16.39%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Aldeyra Therapeutics by the numbers

Aldeyra Therapeutics has a market capitalization of $50.7 million based on 60.36M shares outstanding. With trailing EPS of $-0.31, Aldeyra Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.2% below its 50-day average and 56.8% below its 200-day average.

Average daily trading volume is 1.16M shares, or about $972,303 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ALDX valuation vs. peer median

ALDX compared with the median of 8 peer companies
MetricALDXPeer medianDifference
Market cap$50.70M$51.66M-2%
Avg. volume1.16M114.54K+911%

Peer median across 8 companies: CLNN, ACRV, LFVN, XBIT, CTOR, HRTX, XLO, RFL.

Valuation

Price and trading

Previous close
0.7217
Open
0.69
Day range
0.6589 – 0.8849
52-week range
0.527 – 5.93
52-week change
-83.06%
Beta
—
Volume
2.47M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
50.70M
Forward Pe
-3.50
Eps
-0.31
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.93
Week52 Low
0.53
Avg Volume
1.16M
Shares Outstanding
60.36M
Ma50
0.90
Ma200
1.94
Earnings Date
Nov 5, 2026
Pct From52w High
-85.83%
Pct From52w Low
59.39%

Related